Dialysis Access Treatment Devices | Market Insights | Asia Pacific | 2023
The Asia Pacific dialysis access treatment device market will grow modestly through 2031, driven by the expanding ESRD population, rising uptake of newer products—such as DCBs and HeRO grafts—along with favorable clinical trial results associated these devices, increasing patient access to dialysis care, and government policy reforms improving the accessibility and affordability of treatment for patients. However, the market will be negatively impacted by the COVID-19 pandemic in the short term, as well as cost constraints in the region’s publicly funded healthcare systems and a lack of reimbursement, which will continue to hinder adoption of premium-priced devices and limit the pace of revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for dialysis access treatment products in Asia Pacific from 2019 through 2031.
